SNANF (Sona Nanotech) Change In Receivables : $-0.06 Mil (TTM As of Apr. 2025)

View and export this data going back to 2006. Start your Free Trial

What is Sona Nanotech Change In Receivables?

Sona Nanotech's change in receivables for the quarter that ended in Apr. 2025 was $-0.02 Mil. It means Sona Nanotech's Accounts Receivable increased by $0.02 Mil from Jan. 2025 to Apr. 2025 .

Sona Nanotech's change in receivables for the fiscal year that ended in Oct. 2024 was $0.01 Mil. It means Sona Nanotech's Accounts Receivable declined by $0.01 Mil from Oct. 2023 to Oct. 2024 .

Sona Nanotech's Accounts Receivable for the quarter that ended in Apr. 2025 was $0.08 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sona Nanotech's liquidation value for the three months ended in Apr. 2025 was $-0.33 Mil.

Sona Nanotech Change In Receivables Historical Data

The historical data trend for Sona Nanotech's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sona Nanotech Change In Receivables Chart

Sona Nanotech Annual Data

Trend

Oct14

Oct15

Oct16

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

Change In Receivables

Get a 7-Day Free Trial

-0.03

-0.11

-0.06

0.12

0.01

Sona Nanotech Quarterly Data
	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25	Apr25
Change In Receivables	Get a 7-Day Free Trial															0.02	0.03	-0.07	-	-0.02

Sona Nanotech Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Apr. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.06 Mil.

Sona Nanotech (OTCPK:SNANF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sona Nanotech's Days Sales Outstanding for the quarter that ended in Apr. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.079	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Sona Nanotech's accounts receivable are only considered to be worth 75% of book value:

Sona Nanotech's liquidation value for the quarter that ended in Apr. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.523	-	0.915	+	0.75 * 0.079	+	0.5 * 0
=	-0.33

Sona Nanotech Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sona Nanotech's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Sona Nanotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Sona Nanotech Inc (OTCPK:SNANF) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

SONA:Canada

Address

1969 Upper Water Street, Suite 2001, Purdy’s Wharf Tower II, Halifax, NS, CAN, B3J 3R7

Website

https://www.sonanano.com

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and various biomedical applications. The company's product includes Gemini and Saliva tests.